Stand out for this role — generate a tailored resume and cover letter in about a minute.
Frontier Medicines seeks two experienced Clinical Operations leaders at Director or Senior Director level to drive operational strategy and study delivery for oncology programs, partnering with cross-functional teams and CROs to ensure quality, on-time delivery within budget.
Based in Boston Seaport, these roles require at least 2 onsite days per week and demand deep oncology expertise, global oversight, and strong stakeholder influence across regions.
Frontier Medicines is seeking two experienced Clinical Operations leaders, at the Director or Senior Director level, to drive the operational strategy and execution of our oncology programs as they advance through clinical development. Each of these roles will serve as the operational leader for a program, translating clinical and business strategy into high-quality, on-time study delivery across regions and partners.
Working in close partnership with cross-functional leaders and CROs, you will oversee program-level planning, risk mitigation, vendor management, and budget accountability while ensuring compliance with global regulatory standards. The ideal candidate brings deep oncology experience, strong global study oversight, and the ability to influence stakeholders, anticipate challenges, and deliver results in a dynamic biotech environment.
These roles will be based in our Boston Seaport office, with onsite presence required a minimum of 2 days per week.
At Frontier, we strive to build a diverse and equitable workplace. The salary range for this role is $185,000 - $250,000. Compensation for the role will depend on a number of factors, including candidates' qualifications, skills, competencies and experience. Frontier offers a competitive total rewards package which includes healthcare coverage, 401k and a broad range of other benefits.
This compensation and benefits information is based on Frontier's knowledge as of the date of publication, and may be modified in the future.